Ian Clements
About Ian Clements
Ian Clements serves as the Chief Financial Officer at Mirum Pharmaceuticals, a position he has held since 2019. With extensive experience in investor relations and corporate communications across various pharmaceutical companies, he combines financial acumen with a strong scientific background.
Work at Mirum Pharmaceuticals
Ian Clements has served as the Chief Financial Officer at Mirum Pharmaceuticals since 2019. In this role, he is responsible for overseeing the financial operations of the company, which is based in Foster City, California. His tenure at Mirum has spanned five years, during which he has contributed to the company's financial strategy and investor relations.
Education and Expertise
Ian Clements holds an MBA from The Open University, which he completed from 2000 to 2003. He also earned a BSc in Chemistry from Staffordshire University between 1987 and 1991. Additionally, he obtained a PhD in Chemistry from The University of Manchester, studying from 1991 to 1995. His educational background supports his unique combination of expertise in financial, scientific, and technology sectors.
Background
Ian Clements has a diverse professional background, having worked in various roles across the pharmaceutical and biotechnology industries. Prior to his current position, he held significant roles at companies such as Dermira, Inc., Tobira Therapeutics, and Avanir Pharmaceuticals. His experience includes investor relations and corporate communications, which have been pivotal in his career.
Achievements
Throughout his career, Ian Clements has developed a strong reputation as an accomplished company spokesperson, skilled in media and analyst relations. He has a proven track record in strategic analysis and planning, contributing to effective marketing leadership and financial management. His expertise includes designing and executing corporate communications campaigns across various markets.
Professional Experience
Ian Clements has held multiple positions in the pharmaceutical and biotechnology sectors. His previous roles include Senior Director of Investor Relations and Corporate Communications at SEQUENOM, VP of Investor Relations at Dermira, Inc., and Senior Vice President at The Trout Group. His extensive experience has equipped him with strong project management and interpersonal skills.